<DOC>
	<DOC>NCT01202240</DOC>
	<brief_summary>Estimate the effect of oral ketoconazole administration (400 mg once daily over 3 days) on the pharmacokinetics (process by which the drug is absorbed, distributed, metabolized, and eliminated by the body) of single 10 mg dose of tasocitinib (CP-690,550) in normal healthy volunteers.</brief_summary>
	<brief_title>Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Tofacitinib</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Healthy male and/or female (nonchildbearing potential) subjects between the ages of 18 and 55 years Clinically significant disease Recent history of serious infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Drug-Drug Interaction</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Tasocitinib (CP-690</keyword>
	<keyword>550)</keyword>
	<keyword>Ketoconazole</keyword>
</DOC>